Market Research News

Tuesday 26 June 2018

Medical laser systems market is expected to reach USD 12.5 billion by 2022 : Grand View Research, Inc.

The global medical laser systems market is expected to reach USD 12.5 billion by 2022, according to a new report by Grand View Research, Inc. Rising demand for minimal and non-invasive procedures by patients is anticipated to be the most impact rendering driver of the market.

Increasing application of these systems for diagnostic purposes, rising geriatric population base, propelling demand for cosmetic surgeries and technological advances in pre-existing laser systems are vital factors driving the demand of this market.

Medical laser systems are being prominently applied in various branches of biology such as urology, cardiology, ophthalmology etc for the purpose of diagnosis, disease management and prevention. Augmenting cases of these disorders is expected to positively impact market growth over the forecast period.

Solid state lasers are anticipated to grow at the fastest rate during the forecast period due to higher reliability, smaller compact designs, lowered cost of purchase and prolonged life span of the systems. Diode lasers are expected to hold a significant market share owing to the introduction of next generation Optically Pumped Semiconductor Lasers (OPSLs) that provide unmatched electrical efficiency.

Full research report on medical laser systems marke analysis: http://www.grandviewresearch.com/industry-analysis/medical-laser-system-market

Further key findings from the report suggest:

· Solid state lasers are expected to grow at the fastest rate of over 10% during the forecast period due to technological advances and increasing application in diagnostic field. Neodynium Yttrium Aluminum Garnet (Nd:Yag) and Potassium titanyl phosphate (KTP) are expected to drive growth over the forecast period.

· On the basis of application segments, urology, cardiology and gynecology are expected to be the top contributors of the medical laser systems market. Statistics provided by the WHO estimate that over 17.5 million people annually are reported with chronic cases of cardiovascular disorder that require surgical follow-up.

· North America held over 35.0% of the market in 2014 due to rising disposable income, rising geriatric population base coupled with increasing cases of age-related disorders and conditions.

· Asia Pacific is anticipated to witness lucrative growth and capture over 25.0% share of the global market by 2022. Rising disposal income, increasing awareness and volume of cosmetic surgeries, increasing incidences of diabetic retinopathy, rheumatoid arthritis and dental caries are key drivers for the medical laser systems market growth within the region.

· Eminent players of this market include IRIDEX Corp., Lumenis Ltd., Syneron-Candela, Photomedex Inc., Spectranetics Corp., Biolase Inc., Bioform Medica Inc., biolitec, and Cutera.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global medical laser systems market on the basis of products and region:

Medical Laser Systems Product Outlook (Revenue in USD Million, 2012 - 2022)

· Diode Lasers

· Solid State (Crystal) Lasers

o Holmium Yttrium Aluminum Garnet (Ho:Yag) lasers

o Erbium Yttrium Aluminum Garnet (Er:Yag) lasers

o Neodynium Yttrium Aluminum Garnet (Nd:Yag) lasers

o Potassium Titanyl Phosphate (KTP)

o Alexandrite lasers

o Ruby lasers

· Gas Lasers

o CO2

o Argon

o Krypton

o Metal Vapor (Cu and Au)

o Helium-Neon

o Excimer

· Dye Lasers

Medical Laser Systems Application Outlook (Revenue in USD Million, 2012 - 2022)

· Dermatology

· Ophthalmology

· Gynecology

· Urology

· Dentistry

· Cardiology

· Others

Medical Laser Systems Regional Outlook (Revenue in USD Million, 2012 - 2022)

· North America

· Europe

· Asia Pacific

· RoW

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-medical-laser-systems-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Solar Control Glass Market Size Likely To Reach A Valuation Of Usd 8.88 Billion By 2024 : Grand View Research, Inc.

The global solar control glass market is expected to reach USD 8.88 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand owing to positive construction and automotive industry outlook is expected to propel solar control glass market growth.

Solar control glass allows a significant amount of sunlight to pass through and reflects a large amount of solar heat thus making it suitable for green building applications. The growing trend of green buildings constructions with high energy efficiency and reduced CO₂ emissions is expected to drive market demand for solar control glass over the forecast period.

The demand is driven by countries such as U.S and Germany where there is a growing trend of green buildings. The favorable government policies in China and Japan are expected to boost demand for this product. The growing usage in the automotive industry owing to reduced air conditioning costs will have a positive impact on demand for solar control glass over the forecast period.

Full research report on solar control glass market analysis:

http://www.grandviewresearch.com/industry-analysis/solar-control-glass

Further key findings from the report suggest

· Commercial buildings will witness the fastest growth at a CAGR of 9.1% in terms of volume from 2016 to 2024 as a result of increasing projects that are energy efficient coupled with government regulations promoting energy efficient buildings.

· European market was valued at USD 1.74 billion in 2015 and will show significant rise owing to growing demand for commercial buildings with provisions to reduce the CO₂ emissions resulting from the air conditioning in the building. Growing automotive industry in in Germany is expected to propel demand for this product.

· MEA will witness significant revenue growth at a CAGR of 10.1% from 2016 to 2024 in light of the increasing construction projects and arid climatic conditions in that region.

· Key participants include NSG, AGC Glass Europe, and Saint-Gobain together accounting for a major market share in 2015. Other prominent players include PPG Glass Industries, Guardian Glass, Sisecam Flat Glass and Euroglas GmbH.

· Companies are focusing on increasing their footprint within the global solar control glass industry through various strategic initiatives. For instance, in June 2016, PPG announced the sale of its European fiberglass operations to Nippon Electric Glass Co. to focus on growing market of low emissivity solar control glass. In July 2016, AGC introduced Ipasol neutral 70/37 and Ipasol light gray 60/33 solar control glass products in the market to meet the growing demand.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/specialty-glass-ceramic-and-fiber

Grand View Research has segmented the global solar control glass market on the basis of application and region:

Application Outlook (Volume, Million Square Meter; Revenue, USD Million, 2013 - 2024)

· Commercial Buildings

· Residential Buildings

· Automotive

Regional Outlook (Volume, Million Square Meter; Revenue, USD Million, 2013 - 2024)

· North America

o U.S.

· Europe

o Germany

o UK

· Asia Pacific

o China

o Japan

· Latin America

o Brazil

· MEA

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-solar-control-glass-market

Bioprosthetics Market expected to reach USD 6.41 billion by 2024 : Grand View Research, Inc.

The global bioprosthetics market is expected to reach USD 6.41 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Full research report on bioprosthetics market analysis:

http://www.grandviewresearch.com/industry-analysis/bioprosthetics-market

Further key findings from the study suggest:

· The allograft segment is expected to exhibit growth at a significant CAGR of over 10.0% during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia

· The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 11.0% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction

· Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments

· In 2015, Europe dominated the overall bioprosthetics market at over 40.0%. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region

· For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe

· Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion

· For instance, in March 2016, Edwards Lifesciences Corporation received an approval for the SAPIEN 3 Valve in Japan for the treatment of patients suffering from aortic stenosis. Additionally, the rising involvement of the players in this vertical toward developing and enhancing the supply of bioprosthetics through strategic alliances is likely to provide the market with a high potential growth platform in the future

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the bioprosthetics market on the basis of type, application,and region:

Global bioprosthetics type outlook (Revenue, USD Million, 2013 - 2024)

· Allograft

· Xenograft

o Porcine

o Bovine

Global bioprosthetics application outlook (Revenue, USD Million, 2013 - 2024)

· Cardiovascular

· Plastic surgery & wound healing

Bioprosthetics regional outlook (Revenue, USD Million, 2013 - 2024)

· North America

o U.S.

o Canada

· Europe

o UK

o Germany

· Asia Pacific

o Japan

o China

o India

· Latin America

o Mexico

o Brazil

· MEA

o South Africa

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-bioprosthetics-market

Nephrology And Urology Devices Market Size Likely To Reach A Valuation Of Around USD 31.3 Billion By 2024 : Grand View Research, Inc.

The global nephrology andurology devices market size is expected to reach USD 31.3 billion by 2024, according to a new report by Grand View Research, Inc., exhibiting a 7.1% CAGR during the forecast period. Increasing prevalence of chronic kidney diseases is expected to fuel market growth.

This high prevalence of diseases can be attributed to unhealthy lifestyle habits of people around the world. Moreover, growing geriatric population, who are more prone to hypertension, obesity, diabetes, urinary disorders, and other kidney chronic conditions, is expected to fuel demand for nephrology and urology devices.

Advancements in device technology, such as inclusion of prosthetics in urology, percutaneous methods for stone disintegration and extraction, and extracorporeal shockwave lithotripsy, are anticipated to boost the market over the forecast period. Furthermore, presence of highly advanced pipeline products such as bioartificial kidney is presumed to present the market with lucrative growth opportunities in future.

Increase in demand for minimally invasive techniques is also likely to propel the market in the coming years. Nephrology and urology devices facilitate early diagnosis and shorter treatment duration in most surgical procedures. Minimal pain, heightened cost efficiency, safety, efficacy, rapid recovery, and reduced hospital stay are other benefits offered by these devices. This is expected to boost adoption over the forecast period.

Full research report on nephrology and urology devices market analysis:

https://www.grandviewresearch.com/industry-analysis/nephrology-urology-devices-market

Further key findings from the report suggest:

· The global urology segment is anticipated to reach USD 21.4 billion by 2024, at a CAGR of 6.9% from 2016 to 2024

· By type, the benign prostatic hyperplasia segment is anticipated to witness lucrative growth over the forecast period

· Europe held the dominant revenue share as of 2015 owing to a large target population. Growth across this region is primarily driven by presence of prominent market players implementing extensive expansion strategies such as product development and mergers and acquisitions

· Asia Pacific, especially countries such as India and China, is expected to observe remarkable growth in the coming years

· The global industry is dominated by few players and is marked by extensive new product development and high-end investments in R&D. Level of competition is expected to remain high over the forecast period

· Some of the key players in the market are Baxter International, Inc.; Fresenius Medical Care AG & Co. KGaA; Boston Scientific; and C.R. Bard Inc.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global nephrology and urology devices market on the basis of type and region:

Nephrology and Urology Devices Type Outlook (Revenue, USD Billion, 2013 - 2024)

· Dialysis

· Urinary Stone

o Ureteral stents

o Lithotripters

· Urinary Incontinence & Pelvic Organ Prolapsed

o Sacral neuromodulation

o Vaginal meshes & slings

o Ureteral inserts & pessaries

· Benign Prostatic Hyperplasia

o Catheter ablation

o Prostatic stents

· Endoscopy

· Others

Nephrology and Urology Devices Regional Outlook (Revenue, USD Billion, 2013 - 2024)

· North America

o U.S.

o Canada

· Europe

o U.K.

o Germany

· Asia Pacific

o Japan

o China

o India

· Latin America

o Brazil

o Mexico

· Middle East & Africa

o South Africa

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/nephrology-urology-devices-market